Literature DB >> 20015306

Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

H Masuyama1, T Segawa, Y Sumida, A Masumoto, S Inoue, Y Akahori, Y Hiramatsu.   

Abstract

OBJECTIVE: Circulating angiogenic factors have been shown to be important in the pathophysiology of pre-eclampsia. Blood levels of adipocytokines differ in pre-eclampsia relative to controls and may also play an important role in disease pathogenesis. Differences in the circulating levels of these molecules were compared between matched normotensive controls and women with pre-eclampsia with onset before or at/after 32 weeks, and according to whether the women were of normal weight (18.5 < body mass index < 25) or overweight.
DESIGN: A cross-sectional study of 110 pregnant Japanese women who visited the Department of Obstetrics and Gynecology, Okayama University Hospital, Okayama, Japan.
SETTING: Tertiary referral centre serving 2000 births.
METHODS: Serum concentrations of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), soluble endoglin (sEng), adiponectin and leptin were measured in women with pre-eclampsia and in normotensive controls matched for age, gestational week, parity and body mass index. Main outcome measures Serum levels of sFlt-1, PlGF, the sFlt-1/PlGF ratio, sEng, adiponectin and leptin.
RESULTS: The sFlt-1/PlGF ratio in early-onset pre-eclampsia was significantly higher than that in late-onset pre-eclampsia (112.0 +/- 30.2 versus 45.4 +/- 43.8, P = 0.037). There was a significant elevation of leptin in both subtypes relative to controls (early: 58.6 +/- 18.3 ng/ml versus 26.0 +/- 6.7 ng/ml, P = 0.001; late: 39.5 +/- 9.2 ng/ml versus 22.0 +/- 4.3 ng/ml, P = 0.005), but adiponectin was increased only in late-onset pre-eclampsia (36.5 +/- 13.4 microg/ml versus 12.0 +/- 4.3 microg/ml, P = 0.003). Significant differences in angiogenic factors and adiponectin were found between normal and overweight women only in late-onset pre-eclampsia.
CONCLUSIONS: These data suggest that there are different profiles of angiogenic factors and adipocytokines between women who develop early- and late-onset pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015306     DOI: 10.1111/j.1471-0528.2009.02453.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  29 in total

1.  Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study.

Authors:  Maria Dalamaga; Sindhu K Srinivas; Michal A Elovitz; John Chamberland; Christos S Mantzoros
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

2.  Preeclampsia, gestational hypertension and subsequent hypothyroidism.

Authors:  Tuija Männistö; S Ananth Karumanchi; Anneli Pouta; Marja Vääräsmäki; Pauline Mendola; Satu Miettola; Heljä-Marja Surcel; Aini Bloigu; Aimo Ruokonen; Marjo-Riitta Järvelin; Anna-Liisa Hartikainen; Eila Suvanto
Journal:  Pregnancy Hypertens       Date:  2012-09-21       Impact factor: 2.899

Review 3.  A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy.

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Donatella Spotti; Franca Giacchino; Rossella Attini; Monica Limardo; Stefania Maxia; Antioco Fois; Linda Gammaro; Tullia Todros
Journal:  J Nephrol       Date:  2017-04-22       Impact factor: 3.902

Review 4.  Anti-angiogenesis and Preeclampsia in 2016.

Authors:  Susanne Schrey-Petersen; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

5.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

6.  Differences in uterine artery blood flow and fetal growth between the early and late onset of pregnancy-induced hypertension.

Authors:  Takashi Mitsui; Hisashi Masuyama; Jota Maki; Shoko Tamada; Yumika Hirano; Eriko Eto; Etsuko Nobumoto; Kei Hayata; Yuji Hiramatsu
Journal:  J Med Ultrason (2001)       Date:  2016-06-28       Impact factor: 1.314

Review 7.  Preeclampsia beyond pregnancy: long-term consequences for mother and child.

Authors:  Hannah R Turbeville; Jennifer M Sasser
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-06

8.  Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

Authors:  Eleazar Soto; Roberto Romero; Juan Pedro Kusanovic; Giovanna Ogge; Youssef Hussein; Lami Yeo; Sonia S Hassan; Chong Jai Kim; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-25

9.  Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia.

Authors:  Giovanna Ogge; Tinnakorn Chaiworapongsa; Roberto Romero; Youssef Hussein; Juan Pedro Kusanovic; Lami Yeo; Chong Jai Kim; Sonia S Hassan
Journal:  J Perinat Med       Date:  2011-08-17       Impact factor: 1.901

Review 10.  Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.

Authors:  Elizabeth Phipps; Devika Prasanna; Wunnie Brima; Belinda Jim
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.